BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy
Mathé, G.; Halle-Pannenko, O.; Bourut, C.
National Cancer Institute Monograph 39(8): 107-113
1973
ISSN/ISBN: 0083-1921 PMID: 4150737 Document Number: 67894
Document emailed within 1 workday
Related Documents
Papermaster, B.W.; Kaltenbach, M.L. 1978: Lymphokine preparations: a new approach to cancer immunotherapy Missouri Medicine 75(12): 607-609; 612Stanislavskiĭ, E.S.; Joó, I. 1983: Immunoprophylaxis and immunotherapy of infection caused by Pseudomonas aeruginosa: research results and prospects Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1983(7): 22-31
Schlag, P.M. 1994: Adjuvant systemic chemo- or immunotherapy of colon cancer Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 65(6): 503-508
Gordon, D.S. 1977: Clinical immunotherapy experiences in the Southeastern Cancer Study Group Developments in Biological Standardization 38: 567-572
Yang, S.C.; Owen-Schaub, L.; Mendiguren-Rodriguez, A.; Grimm, E.A.; Hong, W.K.; Roth, J.A. 1990: Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha Journal of Thoracic and Cardiovascular Surgery 99(1): 8
Hua, Z.; Lu, J.; Li, H. 1996: Clinical study on immunotherapy of ovarian cancer with tumor infiltrating lymphocytes Zhonghua Fu Chan Ke Za Zhi 31(9): 555-557
Minev, B.R.; Guo, F.; Gueorguieva, I.; Kaiser, H.E. 2002: Vaccines for immunotherapy of breast cancer and prostate cancer: new developments and comparative aspects In Vivo 16(6): 405-415
Chiriva-Internati, M. 2011: Sperm protein 17: clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond International Reviews of Immunology 30(2-3): 138-149
Drachenberg, K.J. 1999: Adjuvants for specific immunotherapy past, present, future Arbeiten aus dem Paul-Ehrlich-Institut Zu Frankfurt A.M 93: 275-279; Discussion: 280-281
Little, A.G.; DeMeester, T.R.; Ferguson, M.K.; Skinner, D.B.; Hoffman, P.C.; Skosey, C.; Blough, R.R.; Golomb, H.M. 1986: Modified stage i (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy Surgery 100(4): 621-628
Uggeri, F.; Caprotti, R.; De Grate, L.; Crippa, S.; Nobili, C.; Penati, C.; Romano, F. 2009: Short-term preoperative IL-2 immunotherapy in operable pancreatic cancer: a randomized study Hepato-Gastroenterology 56(91-92): 861-865
Takeda, T.; Nakamura, K.; Sato, M.; Takeda, T.; Tomimaru, Y.; Takeda, H. 2014: The effect of immunotherapy and hyperthermia on patients with advanced or recurrent cancer - analyses by cancer type and recurrence form Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(10): 1261-1263
Hadźiev, S.; Mandulova, P.; Kavaklieva-Dimitrova, J.; Penev, K.; Spassova, M.; Madźarova, S. 1982: BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis Neoplasma 29(1): 93-110
Saha, K.; Kapila, H.; Madan, R.; Shinghal, R.N. 1986: Immunologic tools to decipher efficacy of BCG immunotherapy in advanced breast cancer: a one year follow up study Asian Pacific Journal of Allergy and Immunology 4(2): 139-148
Nukata, Y.; Shiiba, K.; Ebine, N.; Ishii, S.; Matsuno, S. 1995: Oral administration of OK-432 is an effective immunotherapy against colon cancer--a study in a murine mesenteric lymphnode metastasis model Nihon Geka Gakkai Zasshi 96(10): 671-679
Ogura, T.; Sakatani, M. 1985: Randomized controlled study on adjuvant immunotherapy for unresectable lung cancer with Nocardia rubra cell wall skeleton Nihon Kyobu Shikkan Gakkai Zasshi 23(1): 62-67
Tanigawa, K.; Itoh, Y.; Kobayashi, Y. 2016: Improvement of QOL and Immunological Function with Lentinula Edodes Mycelia in Patients Undergoing Cancer Immunotherapy: An Open Pilot Study Alternative Therapies in Health and Medicine 22(4): 36-42
Hattori, T. 1984: Immunotherapy of cancer Nursing Technique 30(4): 518
Velotti, F.; Tubaro, A.; Stoppacciaro, A.; Pettinato, A.; Morrone, S.; Bossola, P.; Napolitano, T.; Miano, L.; Ruco, L.; Piccoli, M. 1990: Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase i study Annali Dell'istituto Superiore di Sanita 26(3-4): 411-421
Lewis, J.J.; Janetzki, S. 1998: A new hotspot for cancer immunotherapy? Cancer Journal from Scientific American 4(5): 298-299